AngioDynamics | ANGO - Ebitda


AngioDynamics reported $-369K in EBITDA for its fiscal quarter ending in February of 2025.





Ebitda Change Date
AngioDynamics USD -369K 2.01M Feb/2025
AtriCure USD 17.8M 2.45M Sep/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
ICU Medical USD 100.31M 36.51M Jun/2025
J&J USD 9.52B 389M Sep/2025
Medtronic USD 2.44B 139M Sep/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 7.73M 7.64M Sep/2024
Smiths 361M 3M Dec/2025
Surmodics USD 1.53M 485K Sep/2024
Tandem Diabetes Care USD 2.77M 4.62M Sep/2025
Teleflex USD 207.62M 15.28M Jun/2025
Terumo JPY 66.76B 10.31B Sep/2025
Trinity Biotech USD -9.6M 7.64M Dec/2024